Oral Biolife Inc.
PrivateLast Round
Series A
Mar 6, 2026
Total Funding Raised
$200,000
Company Overview
Oral Biolife Inc. is a biotechnology company that develops dental therapeutics, including its lead asset Ambrilux Dental Gel, designed for the treatment of periodontal disease through bone regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oral Biolife Inc. Comparables
Compare Oral Biolife Inc. with similar companies based on industry and business-model similarity.
Oral Biolife Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 6, 2026 | ||||
| Seed | Oct 15, 2025 | ||||
| VC Round | Jun 24, 2025 | ||||
| Grant | Jan 25, 2021 |
Oral Biolife Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 36% MoM, reaching 1.5K.
- Nov 30, 2024
Monthly visitors increased 45% MoM.
Oral Biolife Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oral Biolife Inc.'s valuation, stock price, and market status.